Yellowstone Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Yellowstone Partners's MRK Position: Q4 2017 in Review
Yellowstone Partners reduced its Merck (MRK) stake by 22% in Q4 2017, selling an estimated $99K and leaving 6,440 shares worth $346K. The position accounts for 0.2% of the portfolio, ranked #112.
Yellowstone Partners first reported a position in MRK in Q4 2015 and has held it in 4 quarters since. The position peaked at $519K in Q3 2016. 2,008 funds tracked by Wall St. Rank hold MRK as of Q4 2017.
- Yellowstone Partners held 6,440 shares of Merck worth $346K as of Q4 2017.
- Yellowstone Partners sold 1,785 Merck shares in Q4 2017, an estimated $99K.
- Merck made up 0.2% of Yellowstone Partners's portfolio in Q4 2017, its #112 holding.
- Yellowstone Partners first reported a position in Merck in Q4 2015 and has held it in 4 quarters since.
- Yellowstone Partners's Merck position peaked at $519K in Q3 2016.
- 2,008 funds tracked by Wall St. Rank held Merck as of Q4 2017.
Based on Yellowstone Partners's 13F filing for Q4 2017, filed 24 Jan 2018.